Clinical Report: Identification of 'Faggot Auer Rods' in Non-M3 AML

Overview

This report details a case of a 79-year-old male diagnosed with non-M3 acute myeloid leukemia (AML) exhibiting 'faggot-like' Auer rods. The findings highlight the potential for misdiagnosis when relying solely on morphological characteristics.

Background

Acute myeloid leukemia (AML) is a heterogeneous malignancy characterized by the proliferation of myeloid blasts. Accurate classification is crucial for treatment and prognosis, particularly in distinguishing between subtypes such as acute promyelocytic leukemia (APL) and non-M3 AML. Misidentification of Auer rods can lead to inappropriate treatment strategies.

Data Highlights

Case presentation of a 79-year-old male with leukocytosis and abnormal leukocytes in peripheral blood and bone marrow.

Key Findings

• The patient presented with leukocytosis and elevated monocyte percentage.
• Bone marrow aspirate revealed 40% abnormal leukocytes with 'faggot-like' Auer bodies.
• Flow cytometry showed blasts positive for CD117, CD33, and MPO.
• No APL-specific fusion genes were detected, leading to a diagnosis of non-M3 AML.
• Faggot-like Auer bodies are not exclusive to APL and can appear in non-M3 AML.

Clinical Implications

This case emphasizes the importance of molecular testing in the diagnosis of AML to avoid misdiagnosis based on morphology alone. Clinicians should be aware of the potential for similar morphological features in different AML subtypes.

Conclusion

The identification of 'faggot-like' Auer rods in non-M3 AML underscores the need for careful diagnostic evaluation to prevent treatment errors.

Related Resources & Content

1. Blood Cancer Journal, 2024 -- Cellular Signal-Transduction Mechanisms in Acute Myeloid Leukemia Following In Vivo Combination Treatment with ATRA, Valproic Acid, and Theophylline
2. Blood Cancer Journal, 2022 -- Single-Cell Analysis of Hematopoietic Differentiation in NPM1-Mutated Acute Myeloid Leukemia
3. Blood Cancer Journal, 2016 -- Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome
4. Frontiers, 2026 -- The appearance of 'Faggot Auer Rods' in Blasts of Non-M3 Acute Myeloid Leukemia
5. Blood Cancer Journal — Reassessing Genetic Alterations and Prognostic Implications of Ex-M6a Acute Erythroid Leukemia in Light of the Updated WHO Classification
6. Morphologic background and mimics
7. Diagnostic guidance and consensus in 2024–2026
8. AML With Myelodysplasia Related Changes With APL‐Like Morphology - PMC
9. Frontiers | Case Report: Pediatric AML with TBC1D15::RAB21 fusion and FLT3-ITD/NPM1 co-mutation: diagnostic pitfalls in morphologic mimicry of acute promyelocytic leukemia
10. Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS | Haematologica